Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
300244.SZ Stock Summary
Top 10 Correlated ETFs
300244.SZ
In the News
300244.SZ Financial details
Company Rating
Strong Buy
Market Cap
9.59B
Income
-379.88M
Revenue
14.95B
Book val./share
12.55
Cash/share
4.47
Dividend
0.2
Dividend %
0.89%
Employees
13.13K
Optionable
No
Shortable
Yes
Earnings
20 Apr 2024
P/E
-36.99
Forward P/E
-
PEG
2.79
P/S
0.94
P/B
1.79
P/C
3.3
P/FCF
-13.49
Quick Ratio
2.5
Current Ratio
2.81
Debt / Equity
0.57
LT Debt / Equity
0.25
-
-
EPS (TTM)
-0.61
EPS next Y
-
EPS next Q
-
EPS this Y
22.99%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
26.5%
Revenue last 5Y
23.83%
Revenue Q/Q
-4.42%
EPS Q/Q
-74.47%
-
-
-
-
SMA20
-15.79%
SMA50
-20%
SMA100
-36%
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-5%
ROC
0.03%
Gross Margin
30%
Oper. Margin
3%
Profit Margin
-3%
Payout
-88%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
14.91-30.65
52W High
-50.83%
52W Low
+5.36%
RSI
28
Rel Volume
1.29
Avg Volume
10.93M
Volume
14.13M
Perf Week
-7.64%
Perf Month
-26.25%
Perf Quarter
-35.59%
Perf Half Y
-36.31%
-
-
-
-
Beta
0.481
-
-
Volatility
0.59%, 1.61%
Prev Close
1.44%
Price
14.75
Change
-1.01%
300244.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 12.73 | 13.62 | 17.16 | 21.09 | 32.56 | |
Net income per share | 0.71 | 0.93 | 1.29 | 1.87 | 2.3 | |
Operating cash flow per share | 0.68 | 0.78 | 2.49 | 2.12 | 2.63 | |
Free cash flow per share | -0.15 | 0.12 | 1.73 | 1.17 | 1.11 | |
Cash per share | 2.51 | 2.58 | 3.31 | 4.22 | 7.46 | |
Book value per share | 6.72 | 6.42 | 7.57 | 9.42 | 11.96 | |
Tangible book value per share | 5.11 | 5.43 | 7.55 | 9.91 | 13.84 | |
Share holders equity per share | 6.72 | 6.42 | 7.57 | 9.42 | 11.96 | |
Interest debt per share | 6.91 | 5.79 | 6.39 | 7.41 | 10.1 | |
Market cap | 8.19B | 13.73B | 21.27B | 20.83B | 15.66B | |
Enterprise value | 10.09B | 15.8B | 23.28B | 23.01B | 17.47B | |
P/E ratio | 21.08 | 23.86 | 26.49 | 17.91 | 10.92 | |
Price to sales ratio | 1.18 | 1.62 | 2 | 1.59 | 0.77 | |
POCF ratio | 21.95 | 28.42 | 13.75 | 15.8 | 9.55 | |
PFCF ratio | -98.2 | 191.53 | 19.85 | 28.59 | 22.63 | |
P/B Ratio | 2.23 | 3.45 | 4.53 | 3.57 | 2.1 | |
PTB ratio | 2.23 | 3.45 | 4.53 | 3.57 | 2.1 | |
EV to sales | 1.45 | 1.87 | 2.19 | 1.76 | 0.86 | |
Enterprise value over EBITDA | 8.5 | 10.97 | 9.82 | 8.25 | 3.79 | |
EV to operating cash flow | 27.03 | 32.69 | 15.05 | 17.46 | 10.66 | |
EV to free cash flow | -120.93 | 220.35 | 21.73 | 31.59 | 25.26 | |
Earnings yield | 0.05 | 0.04 | 0.04 | 0.06 | 0.09 | |
Free cash flow yield | -0.01 | 0.01 | 0.05 | 0.03 | 0.04 | |
Debt to equity | 0.98 | 0.85 | 0.8 | 0.75 | 0.81 | |
Debt to assets | 0.34 | 0.31 | 0.3 | 0.28 | 0.29 | |
Net debt to EBITDA | 1.6 | 1.43 | 0.85 | 0.78 | 0.39 | |
Current ratio | 1.37 | 1.57 | 1.47 | 1.63 | 2.17 | |
Interest coverage | 4.24 | 5.42 | 10.04 | 7.98 | 13.89 | |
Income quality | 0.63 | 0.84 | 1.45 | 0.89 | 0.88 | |
Dividend Yield | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | |
Payout ratio | 0.45 | 0.4 | 0.33 | 0.23 | 0.21 | |
Sales general and administrative to revenue | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | |
Research and developement to revenue | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0.18 | 0.16 | 0.11 | 0.09 | 0.04 | |
Capex to operating cash flow | -1.22 | -0.85 | -0.31 | -0.45 | -0.58 | |
Capex to revenue | -0.07 | -0.05 | -0.04 | -0.05 | -0.05 | |
Capex to depreciation | -2.57 | -1.66 | -1.62 | -1.19 | -1.19 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | 0 | |
Graham number | 10.36 | 11.58 | 14.85 | 19.93 | 24.89 | |
ROIC | 0.08 | 0.12 | 0.19 | 0.14 | 0.2 | |
Return on tangible assets | 0.04 | 0.06 | 0.07 | 0.08 | 0.07 | |
Graham Net | -2.89 | -0.92 | -0.01 | 0.49 | 2.85 | |
Working capital | 1.66B | 2.43B | 2.61B | 4.21B | 9.04B | |
Tangible asset value | 2.8B | 3.37B | 4.68B | 6.15B | 8.62B | |
Net current asset value | 223.06M | 1.09B | 1.85B | 2.73B | 5.23B | |
Invested capital | 0.98 | 0.85 | 0.8 | 0.75 | 0.81 | |
Average receivables | 2.63B | 3.45B | 4.35B | 5.93B | 8.74B | |
Average payables | 987.91M | 1.31B | 1.42B | 1.85B | 2.65B | |
Average inventory | 936.07M | 1.27B | 1.23B | 1.23B | 1.38B | |
Days sales outstanding | 168.42 | 159.3 | 171.45 | 191.3 | 191.01 | |
Days payables outstanding | 104.39 | 83.46 | 84.78 | 98.22 | 89.53 | |
Days of inventory on hand | 94.74 | 85.72 | 62.29 | 60.17 | 41.07 | |
Receivables turnover | 2.17 | 2.29 | 2.13 | 1.91 | 1.91 | |
Payables turnover | 3.5 | 4.37 | 4.31 | 3.72 | 4.08 | |
Inventory turnover | 3.85 | 4.26 | 5.86 | 6.07 | 8.89 | |
ROE | 0.11 | 0.14 | 0.17 | 0.2 | 0.19 | |
Capex per share | -0.83 | -0.66 | -0.77 | -0.95 | -1.52 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 7.85 | 7.44 | 5.16 | 5.78 | 5.52 | |
Net income per share | 0.88 | -1.61 | 0.41 | 0.47 | 0.12 | |
Operating cash flow per share | 0.88 | -1.61 | 0.41 | 0.41 | 0.54 | |
Free cash flow per share | 0.71 | -2.37 | 0.17 | 0.19 | 0.33 | |
Cash per share | 4.41 | 7.44 | 6.88 | 5.66 | 4.47 | |
Book value per share | 13.41 | 11.92 | 12.07 | 12.42 | 12.55 | |
Tangible book value per share | 14.52 | 13.8 | 14.6 | 15.11 | 15.16 | |
Share holders equity per share | 13.41 | 11.92 | 12.07 | 12.42 | 12.55 | |
Interest debt per share | 8.29 | 9.75 | 9.75 | 8.47 | 7.2 | |
Market cap | 18.02B | 15.71B | 17.96B | 16.02B | 14.69B | |
Enterprise value | 20.97B | 17.52B | 20.15B | 18.07B | 16.79B | |
P/E ratio | 8.22 | -3.91 | 17.62 | 13.67 | 47.33 | |
Price to sales ratio | 3.7 | 3.38 | 5.56 | 4.44 | 4.26 | |
POCF ratio | 32.89 | -15.62 | 70.46 | 62.43 | 43.33 | |
PFCF ratio | 40.59 | -10.62 | 166.51 | 135.05 | 70.27 | |
P/B Ratio | 2.16 | 2.11 | 2.37 | 2.06 | 1.87 | |
PTB ratio | 2.16 | 2.11 | 2.37 | 2.06 | 1.87 | |
EV to sales | 4.3 | 3.77 | 6.23 | 5.01 | 4.86 | |
Enterprise value over EBITDA | 22.15 | -560.32 | 37.73 | 29.13 | 42.71 | |
EV to operating cash flow | 38.26 | -17.43 | 79.07 | 70.43 | 49.52 | |
EV to free cash flow | 47.23 | -11.85 | 186.84 | 152.36 | 80.31 | |
Earnings yield | 0.03 | -0.06 | 0.01 | 0.02 | 0.01 | |
Free cash flow yield | 0.02 | -0.09 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0.61 | 0.81 | 0.8 | 0.67 | 0.57 | |
Debt to assets | 0.24 | 0.29 | 0.29 | 0.26 | 0.24 | |
Net debt to EBITDA | 3.11 | -58.13 | 4.1 | 3.31 | 5.34 | |
Current ratio | 2.21 | 2.17 | 2.34 | 2.66 | 2.81 | |
Interest coverage | 11.31 | -7.62 | 5.29 | 6.3 | 3.99 | |
Income quality | 1 | 1 | 1 | 0.88 | 4.37 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
Payout ratio | 0.11 | -0.06 | 0.25 | 0.55 | 0.68 | |
Sales general and administrative to revenue | 0.18 | -0.15 | 0.06 | -0.03 | 0.16 | |
Research and developement to revenue | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0.06 | 0.04 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | -0.19 | 0.47 | -0.58 | -0.54 | -0.38 | |
Capex to revenue | -0.02 | -0.1 | -0.05 | -0.04 | -0.04 | |
Capex to depreciation | -0.42 | -1.89 | -0.89 | -0.83 | 0.46 | |
Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Graham number | 16.32 | 20.77 | 10.51 | 11.45 | 5.92 | |
ROIC | 0.05 | -0.05 | 0.02 | 0.03 | 0.01 | |
Return on tangible assets | 0.03 | -0.05 | 0.01 | 0.02 | 0 | |
Graham Net | 2.5 | 2.84 | 3.95 | 4.49 | 4.64 | |
Working capital | 8.82B | 9.04B | 9.82B | 9.74B | 9.43B | |
Tangible asset value | 9.02B | 8.62B | 9.15B | 9.44B | 9.48B | |
Net current asset value | 5.36B | 5.23B | 6.16B | 6.26B | 6.29B | |
Invested capital | 0.61 | 0.81 | 0.8 | 0.67 | 0.57 | |
Average receivables | 11.54B | 11.11B | 10.88B | 10.8B | 10.37B | |
Average payables | 3.34B | 3.19B | 2.94B | 2.54B | 2.31B | |
Average inventory | 1.69B | 1.57B | 1.5B | 1.53B | 1.51B | |
Days sales outstanding | 214.02 | 205.31 | 310.46 | 260.81 | 268.12 | |
Days payables outstanding | 94.45 | 79.4 | 115.03 | 86.93 | 87.43 | |
Days of inventory on hand | 49.47 | 36.42 | 65.4 | 55.96 | 57.81 | |
Receivables turnover | 0.42 | 0.44 | 0.29 | 0.35 | 0.34 | |
Payables turnover | 0.95 | 1.13 | 0.78 | 1.04 | 1.03 | |
Inventory turnover | 1.82 | 2.47 | 1.38 | 1.61 | 1.56 | |
ROE | 0.07 | -0.13 | 0.03 | 0.04 | 0.01 | |
Capex per share | -0.17 | -0.76 | -0.23 | -0.22 | -0.21 |
300244.SZ Frequently Asked Questions
What is Dian Diagnostics Group Co.,Ltd. stock symbol ?
Dian Diagnostics Group Co.,Ltd. is a CN stock and trading under the symbol 300244.SZ
What is Dian Diagnostics Group Co.,Ltd. stock quote today ?
Dian Diagnostics Group Co.,Ltd. stock price is $14.75 today.
Is Dian Diagnostics Group Co.,Ltd. stock public?
Yes, Dian Diagnostics Group Co.,Ltd. is a publicly traded company.